Beijing Tong Ren Tang Chinese Medicine Renews PRC Distribution Framework Agreement
I'm PortAI, I can summarize articles.
Beijing Tong Ren Tang Chinese Medicine Co. Ltd. has signed a renewed distribution framework agreement with Tong Ren Tang Holdings, effective December 30, 2025. This agreement allows Tong Ren Tang Group to act as a non-exclusive distributor of the company's Chinese medicine and healthcare products within the PRC, excluding Angong Niuhuang Wan. The terms were negotiated on normal commercial terms, and an independent financial adviser will assist the company's independent non-executive directors regarding the agreement.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments